00:01
So to begin here, we know that there is going to be a placebo group and a treatment group.
00:09
We know that because the placebo is just getting the buffer solution, whereas the treatment group is getting some sort of treatment, we know that these two would be independent.
00:21
However, when we consider the treatment group, the treatment group itself actually breaks down into two different groups.
00:28
We have the gene group and the gene plus nano.
00:37
So these two samples would be not independent.
00:46
If the gene treatment does have some sort of effect, then that effect would be compounded by the addition of the gene nanoparticle combination, but we can't separate out the gene plus or we effectively can't separate out what the effect of the nanoparticle is from the gene in that combination case so that means that we violate the first listed requirement we violate requirement one which requires for anova that the samples are independent random samples.
01:41
So, because of that, we'd have to choose option one.
01:48
Or, pardon me, we'd have to choose option a.
01:52
Assumption 1 is the only assumption not satisfied...